860575 | C8 L-threo-Lactosyl(ß) Ceramide (d18:1/8:0)
D-lactosyl-ß1-1'-N-octanoyl-L-threo-sphingosine

C8 L-threo-Lactosyl(ß) Ceramide (d18:1/8:0)
D-lactosyl-ß1-1'-N-octanoyl-L-threo-sphingosine
β-D-lactosyl-N-octanoyl-L-threo-sphingosine, (1) selectively inhibits caveolar endocytosis and SV40 virus infection, (2) blocks the clustering of lipids and proteins into GSLs and cholesterol-enriched microdomains (rafts) at the PM, and (3) inhibits β1-integrin activation and downstream signaling. Singh, R.D., E.L. Holicky, Z.J. Cheng, S.Y. Kim, C.L. Wheatley, D.L. Marks, R. Bittman, and R.E. Pagano. (2007). Inhibition of caveolar uptake, SV40 infection, and β1-integrin signaling by a nonnatural glycosphingolipid stereoisomer. J Cell Biol 176:895-901.
CAS Registry Number is a Registered Trademark of the American Chemical Society
Chen S, Wang J, Wang M, Lu J, Cai Y, Li B. In vitro fertilization alters phospholipid profiles in mouse placenta. J Assist Reprod Genet. 2019 Jan 4. doi: 10.1007/s10815-018-1387-y. [Epub ahead of print]
PubMed ID: 30610659Singh, R.D., E.L. Holicky, Z.J. Cheng, S.Y. Kim, C.L. Wheatley, D.L. Marks, R. Bittman,and R.E. Pagano. (2007). Inhibition of caveolar uptake, SV40 infection, andβ1-integrin signaling by a nonnatural glycosphingolipid stereoisomer.J Cell Biol 176:895-901.
- Certificate of Analysis (Lot No. 860575P-1MG-A-010 and 6019PGA010)
- Certificate of Analysis (Lot No. 860575P-1MG-B-010 and 6019PGB010)